{ "cik": 1512762, "cik_padded": "0001512762", "entityName": "Coherus Oncology, Inc.", "fiscal_years": [ { "accn": "0001104659-26-025308", "filed": "2026-03-09", "fiscal_year": 2025, "form": "10-K", "fundamental_units": { "cash": "USD", "eps_diluted": "USD/shares", "net_income": "USD", "operating_cash_flow": "USD", "operating_income": "USD", "stockholders_equity": "USD", "total_assets": "USD", "total_liabilities": "USD" }, "fundamentals": { "cash": 88879000.0, "eps_diluted": 1.43, "net_income": 168024000.0, "operating_cash_flow": -138513000.0, "operating_income": -181134000.0, "stockholders_equity": 61014000.0, "total_assets": 258343000.0, "total_liabilities": 197329000.0 }, "period_end": "2025-12-31", "ratio_units": { "leverage": "ratio", "roa_avg2y": "ratio", "roa_period_end": "ratio", "roe_avg2y": "ratio", "roe_period_end": "ratio" }, "ratios": { "leverage": 3.2341593732585965, "roa_avg2y": 0.47539879696014575, "roa_period_end": 0.6503911466538671, "roe_avg2y": -4.734670874661857, "roe_period_end": 2.753859769888878 } }, { "accn": "0001104659-26-025308", "filed": "2026-03-09", "fiscal_year": 2024, "form": "10-K", "fundamental_units": { "cash": "USD", "eps_diluted": "USD/shares", "net_income": "USD", "operating_cash_flow": "USD", "operating_income": "USD", "stockholders_equity": "USD", "total_assets": "USD", "total_liabilities": "USD" }, "fundamentals": { "cash": 125987000.0, "eps_diluted": 0.25, "net_income": 28507000.0, "operating_cash_flow": -20440000.0, "operating_income": -199653000.0, "stockholders_equity": -131990000.0, "total_assets": 448533000.0, "total_liabilities": 580523000.0 }, "period_end": "2024-12-31", "ratio_units": { "roa_avg2y": "ratio", "roa_period_end": "ratio", "roe_avg2y": "ratio" }, "ratios": { "roa_avg2y": 0.05288196212540707, "roa_period_end": 0.06355608171528071, "roe_avg2y": -0.17520397031482876 } }, { "accn": "0001104659-26-025308", "filed": "2026-03-09", "fiscal_year": 2023, "form": "10-K", "fundamental_units": { "cash": "USD", "eps_diluted": "USD/shares", "net_income": "USD", "operating_cash_flow": "USD", "operating_income": "USD", "stockholders_equity": "USD", "total_assets": "USD", "total_liabilities": "USD" }, "fundamentals": { "cash": 102891000.0, "eps_diluted": -2.53, "net_income": -237892000.0, "operating_cash_flow": -174884000.0, "operating_income": -203199000.0, "stockholders_equity": -193425000.0, "total_assets": 629604000.0, "total_liabilities": 823029000.0 }, "period_end": "2023-12-31", "ratio_units": { "roa_avg2y": "ratio", "roa_period_end": "ratio", "roe_avg2y": "ratio" }, "ratios": { "roa_avg2y": -0.42846014817403016, "roa_period_end": -0.37784385105558416, "roe_avg2y": 1.4380960153305344 } }, { "accn": "0001558370-25-003126", "filed": "2025-03-17", "fiscal_year": 2022, "form": "10-K", "fundamental_units": { "cash": "USD", "eps_diluted": "USD/shares", "net_income": "USD", "operating_cash_flow": "USD", "operating_income": "USD", "stockholders_equity": "USD", "total_assets": "USD", "total_liabilities": "USD" }, "fundamentals": { "cash": 63547000.0, "eps_diluted": -3.76, "net_income": -291754000.0, "operating_cash_flow": -241124000.0, "operating_income": -256880000.0, "stockholders_equity": -137418000.0, "total_assets": 480847000.0, "total_liabilities": 618265000.0 }, "period_end": "2022-12-31", "ratio_units": { "roa_avg2y": "ratio", "roa_period_end": "ratio", "roe_avg2y": "ratio" }, "ratios": { "roa_avg2y": -0.5029456610649545, "roa_period_end": -0.6067501720921624, "roe_avg2y": 14.700896906177567 } }, { "accn": "0001558370-25-003126", "filed": "2025-03-17", "fiscal_year": 2021, "form": "10-K", "fundamental_units": { "cash": "USD", "eps_diluted": "USD/shares", "net_income": "USD", "operating_cash_flow": "USD", "operating_income": "USD", "stockholders_equity": "USD", "total_assets": "USD", "total_liabilities": "USD" }, "fundamentals": { "cash": 417195000.0, "eps_diluted": -3.81, "net_income": -287100000.0, "operating_cash_flow": -37432000.0, "operating_income": -263858000.0, "stockholders_equity": 97726000.0, "total_assets": 679334000.0, "total_liabilities": 581608000.0 }, "period_end": "2021-12-31", "ratio_units": { "leverage": "ratio", "roa_avg2y": "ratio", "roa_period_end": "ratio", "roe_avg2y": "ratio", "roe_period_end": "ratio" }, "ratios": { "leverage": 5.951415181220964, "roa_avg2y": -0.37751901237554925, "roa_period_end": -0.4226198011581932, "roe_avg2y": -1.5162397676260893, "roe_period_end": -2.9378057016556496 } }, { "accn": "0001558370-24-003436", "filed": "2024-03-15", "fiscal_year": 2020, "form": "10-K", "fundamental_units": { "cash": "USD", "eps_diluted": "USD/shares", "net_income": "USD", "operating_cash_flow": "USD", "operating_income": "USD", "stockholders_equity": "USD", "total_assets": "USD", "total_liabilities": "USD" }, "fundamentals": { "cash": 541158000.0, "eps_diluted": 1.62, "net_income": 132244000.0, "operating_cash_flow": 154145000.0, "operating_income": 156319000.0, "stockholders_equity": 280974000.0, "total_assets": 841649000.0, "total_liabilities": 560675000.0 }, "period_end": "2020-12-31", "ratio_units": { "leverage": "ratio", "roa_avg2y": "ratio", "roa_period_end": "ratio", "roe_avg2y": "ratio", "roe_period_end": "ratio" }, "ratios": { "leverage": 1.995469331681935, "roa_avg2y": 0.2114929440513811, "roa_period_end": 0.15712488222525067, "roe_avg2y": 0.684868509637793, "roe_period_end": 0.47066276594987433 } }, { "accn": "0001558370-23-002917", "filed": "2023-03-06", "fiscal_year": 2019, "form": "10-K", "fundamental_units": { "cash": "USD", "eps_diluted": "USD/shares", "net_income": "USD", "operating_cash_flow": "USD", "operating_income": "USD", "stockholders_equity": "USD", "total_assets": "USD", "total_liabilities": "USD" }, "fundamentals": { "cash": 177668000.0, "eps_diluted": 1.23, "net_income": 89833000.0, "operating_cash_flow": 28355000.0, "operating_income": 107768000.0, "stockholders_equity": 105214000.0, "total_assets": 408927000.0, "total_liabilities": 303713000.0 }, "period_end": "2019-12-31", "ratio_units": { "leverage": "ratio", "roa_avg2y": "ratio", "roa_period_end": "ratio", "roe_avg2y": "ratio", "roe_period_end": "ratio" }, "ratios": { "leverage": 2.886621552264908, "roa_avg2y": 0.3533991353163098, "roa_period_end": 0.21967979614943497, "roe_avg2y": 2.696756375425904, "roe_period_end": 0.8538122303115556 } }, { "accn": "0001558370-22-001764", "filed": "2022-02-23", "fiscal_year": 2018, "form": "10-K", "fundamental_units": { "cash": "USD", "eps_diluted": "USD/shares", "net_income": "USD", "operating_cash_flow": "USD", "operating_income": "USD", "stockholders_equity": "USD", "total_assets": "USD", "total_liabilities": "USD" }, "fundamentals": { "cash": 72356000.0, "eps_diluted": -3.22, "net_income": -209339000.0, "operating_cash_flow": -159266000.0, "operating_income": -204416000.0, "stockholders_equity": -38591000.0, "total_assets": 99467000.0, "total_liabilities": 138058000.0 }, "period_end": "2018-12-31", "ratio_units": { "roa_avg2y": "ratio", "roe_avg2y": "ratio" }, "ratios": { "roa_avg2y": -1.597532032448355, "roe_avg2y": 51.97095332671301 } }, { "accn": "0001564590-19-005470", "filed": "2021-02-25", "fiscal_year": 2017, "form": "10-K", "fundamental_units": { "cash": "USD", "eps_diluted": "USD/shares", "net_income": "USD", "operating_cash_flow": "USD", "operating_income": "USD", "stockholders_equity": "USD", "total_assets": "USD", "total_liabilities": "USD" }, "fundamentals": { "cash": 126911000.0, "eps_diluted": -4.48, "net_income": -238170000.0, "operating_cash_flow": -200286000.0, "operating_income": -232136000.0, "stockholders_equity": 30535000.0, "total_assets": 162611000.0, "total_liabilities": 132076000.0 }, "period_end": "2017-12-31", "ratio_units": { "leverage": "ratio", "roa_avg2y": "ratio", "roa_period_end": "ratio", "roe_avg2y": "ratio" }, "ratios": { "leverage": 4.325397085311937, "roa_avg2y": -1.3964983465065552, "roa_period_end": -1.464661062289759, "roe_avg2y": -9.328659276957424 } }, { "accn": "0001564590-19-005470", "filed": "2019-02-28", "fiscal_year": 2016, "form": "10-K", "fundamental_units": { "cash": "USD", "net_income": "USD", "operating_cash_flow": "USD", "operating_income": "USD", "stockholders_equity": "USD", "total_assets": "USD", "total_liabilities": "USD" }, "fundamentals": { "cash": 124947000.0, "net_income": -127337000.0, "operating_cash_flow": -252545000.0, "operating_income": -115931000.0, "stockholders_equity": 20527000.0, "total_assets": 178485000.0, "total_liabilities": 159131000.0 }, "period_end": "2016-12-31", "ratio_units": { "leverage": "ratio", "roa_period_end": "ratio" }, "ratios": { "leverage": 7.752277488186291, "roa_period_end": -0.7134325013306441 } } ], "latest_filing": { "accn": "0001104659-26-025308", "filed": "2026-03-09", "form": "10-K" }, "note": "Static grepcent export of verified SEC companyfacts-derived values. Monetary values are raw reported units from grepcent's resolved facts; no scaling and no FX conversion. Capex, dividends, and buybacks are reported as positive outflow magnitudes. ROE/ROA include both period-end basis (site-consistent) and average-of-two-years basis where the prior-year denominator exists.", "schema_version": "1", "sic": "2836", "sic_description": "Biological Products, (No Diagnostic Substances)", "source_urls": { "sec_companyfacts": "https://data.sec.gov/api/xbrl/companyfacts/CIK0001512762.json", "sec_submissions": "https://data.sec.gov/submissions/CIK0001512762.json" }, "ticker": "CHRS" }